Related Experiment Video
Updated: Oct 13, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Regulation of TLR4 signaling through the TRAF6/sNASP axis by reversible phosphorylation mediated by CK2 and PP4
Feng-Ming Yang1, Hui-Ming Chang2,3,4, Edward T H Yeh5,4
1School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, Taiwan 110301.
Abstract:
Recognition of invading pathogens by Toll-like receptors (TLRs) activates innate immunity through signaling pathways that involved multiple protein kinases and phosphatases. We previously demonstrated that somatic nuclear autoantigenic sperm protein (sNASP) binds to TNF receptor-associated factor 6 (TRAF6) in the resting state. Upon TLR4 activation, a signaling complex consisting of TRAF6, sNASP, interleukin (IL)-1 receptor-associated kinase 4, and casein kinase 2 (CK2) is formed. CK2 then phosphorylates sNASP to release phospho-sNASP (p-sNASP) from TRAF6, initiating downstream signaling pathways. Here, we showed that protein phosphatase 4 (PP4) is the specific sNASP phosphatase that negatively regulates TLR4-induced TRAF6 activation and its downstream signaling pathway. Mechanistically, PP4 is directly recruited by phosphorylated sNASP to dephosphorylate p-sNASP to terminate TRAF6 activation. Ectopic expression of PP4 specifically inhibited sNASP-dependent proinflammatory cytokine production and downstream signaling following bacterial lipopolysaccharide (LPS) treatment, whereas silencing PP4 had the opposite effect. Primary macrophages and mice infected with recombinant adenovirus carrying a gene encoding PP4 (Ad-PP4) showed significant reduction in IL-6 and TNF-α production. Survival of Ad-PP4-infected mice was markedly increased due to a better ability to clear bacteria in a sepsis model. These results indicate that the serine/threonine phosphatase PP4 functions as a negative regulator of innate immunity by regulating the binding of sNASP to TRAF6.
Insights
Protein phosphatase 4 (PP4) acts as a negative regulator in innate immunity. It dephosphorylates somatic nuclear autoantigenic sperm protein (sNASP), thereby inhibiting Toll-like receptor 4 (TLR4)-induced signaling and enhancing sepsis survival.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Toll-like receptors (TLRs) activate innate immunity via complex signaling pathways involving kinases and phosphatases.
- Somatic nuclear autoantigenic sperm protein (sNASP) binds TNF receptor-associated factor 6 (TRAF6) in resting cells.
- Upon TLR4 activation, a signaling complex including TRAF6, sNASP, IL-1 receptor-associated kinase 4, and casein kinase 2 (CK2) is formed, with CK2 phosphorylating sNASP.
Purpose of the Study:
- To identify the specific phosphatase that dephosphorylates sNASP.
- To elucidate the role of this phosphatase in regulating TLR4-induced innate immune signaling.
- To investigate the therapeutic potential of modulating this phosphatase activity in infection models.
Main Methods:
- Biochemical assays to identify sNASP phosphatase activity.
- Cell-based experiments using ectopic expression and gene silencing of protein phosphatase 4 (PP4).
- In vivo studies using mouse models of bacterial infection and sepsis, employing recombinant adenovirus for gene delivery.
Main Results:
- Protein phosphatase 4 (PP4) was identified as the specific phosphatase for sNASP.
- PP4 dephosphorylates phospho-sNASP (p-sNASP), terminating TRAF6 activation and downstream signaling.
- Ectopic PP4 expression inhibited pro-inflammatory cytokine production (IL-6, TNF-α) and improved survival in a sepsis model, while PP4 silencing had opposite effects.
Conclusions:
- PP4 acts as a negative regulator of TLR4-induced innate immunity by modulating the sNASP-TRAF6 interaction.
- Targeting PP4 offers a potential therapeutic strategy to enhance innate immune responses and combat bacterial infections.
- The sNASP-TRAF6-PP4 axis represents a novel regulatory mechanism in innate immune signaling.
Related Concept Videos
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
Amplifying Signals via Enzymatic Cascade
PI3K/mTOR/AKT Signaling Pathway
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Receptor Tyrosine Kinases

